Research Progress and Prospects of Flavonoids in the Treatment of Hyperlipidemia: A Narrative Review
Molecules · 24.07.2025 · 30 (15) · 3103
DOI: 10.3390/molecules30153103 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 24.07.2025. Verfasst von Xingtong Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin 150040, China. Hauptthemen laut MEDLINE: Hyperlipidemias, Flavonoids, Hypolipidemic Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 232 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, "Basic Research Support Program for Outstanding Young Teachers" of Heilongjiang Provincial Undergraduate Universities, Heilongjiang Provincial Undergraduate Universities.
Abstract (Originalsprache)
Hyperlipidemia (HLP) is a disorder of human lipid metabolism or transport, primarily characterized by abnormally elevated levels of total cholesterol (TC), triglycerides (TGs), and low-density lipoprotein cholesterol (LDL-C) in the blood. It is a key factor contributing to the development of non-alcoholic fatty liver disease, obesity, diabetes, atherosclerosis, and cardiovascular and cerebrovascular diseases. Statistics show that the prevalence of dyslipidemia among Chinese adults is as high as 35.6%, and it has shown a trend of younger onset in recent years, posing a serious threat to public health. Therefore, the prevention and treatment of dyslipidemia carry significant social significance. The pathogenesis of hyperlipidemia is complex and diverse, and currently used medications are often accompanied by side effects during treatment, making the research and development of new therapeutic approaches a current focus. Numerous studies have shown that flavonoids, which are abundant in most medicinal plants, fruits, and vegetables, exert effects on regulating lipid homeostasis and treating hyperlipidemia through a multi-target mechanism. These compounds have demonstrated significant effects in inhibiting lipid synthesis, blocking lipid absorption, promoting cholesterol uptake, enhancing reverse cholesterol transport, and suppressing oxidative stress, inflammation, and intestinal microbiota disorders. This article reviews the latest progress in the mechanisms of flavonoids in the treatment of hyperlipidemia, providing a theoretical basis for future research on drugs for hyperlipidemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Förderung
- National Natural Science Foundation of China
- "Basic Research Support Program for Outstanding Young Teachers" of Heilongjiang Provincial Undergraduate Universities
- Heilongjiang Provincial Undergraduate Universities
Zitieren
APA
Chen, X., Yang, J., Zhou, Y., Wang, Q., Xue, S., Zhang, Y., & Niu, W. (2025). Research Progress and Prospects of Flavonoids in the Treatment of Hyperlipidemia: A Narrative Review. Molecules, 30(15), 3103. https://doi.org/10.3390/molecules30153103
Vancouver
Chen X, Yang J, Zhou Y, Wang Q, Xue S, Zhang Y, et al. Research Progress and Prospects of Flavonoids in the Treatment of Hyperlipidemia: A Narrative Review. Molecules. 2025;30(15):3103. doi:10.3390/molecules30153103
BibTeX
@article{Chen2025,
author = {Chen, Xingtong and Yang, Jinbiao and Zhou, Yunyue and Wang, Qiao and Xue, Shuang and Zhang, Yukun and Niu, Wenying},
title = {Research Progress and Prospects of Flavonoids in the Treatment of Hyperlipidemia: A Narrative Review},
journal = {Molecules},
year = {2025},
volume = {30},
number = {15},
pages = {3103},
doi = {10.3390/molecules30153103}
}
EUVIMED